BoneCT
AI solution for detecting secondary bone lesions
BoneCT gives radiologists an AI-powered second reader for CT scans, seamlessly integrated into their workflow. It detects and highlights bone metastases, supporting early detection and more consistent patient management.
Designed for oncology imaging
BoneCT focuses on identifying secondary bone lesions, a frequent complication in cancer patients, by analyzing CT scans of the spine, pelvis, and long bones. It flags suspicious bone lesions to support staging and monitoring.
See BoneCT in Action
Indication
A 35-year-old male presenting for staging evaluation after a diagnosis of non-seminomatous germ cell tumor.
Results
BoneCT detected multiple sclerotic secondary bone lesions on the spine.
For Adults
BoneCT is intended to be used on CT scans of adult patients aged 18 and over
Supports all soft kernel CT Scan
BoneCT supports CT scans with or without contrast, with slice thickness up to 3 mm.
Specific features
Discover more about BoneCT
Lesion locator on scout view
BoneCT analyzes each detection on the scout view, localizes the position of the suspicious lesion, and highlights the slice number for easy review.
Enhanced detection. Precise insights.
BoneCT sensitivity is
21% higher
for secondary bone lesions¹
Sensitivity of
90%
for large secondary bone lesions²
BoneCT results in
26% fewer
missed secondary bone lesions³
Boost your workflow with the power of advanced integrations
Designed with radiologists, our workflow integrations blend effortlessly into daily routines, enhancing speed, clarity, and confidence at every step.
AI-powered Worklist
Worklist now highlights AI results, findings, and automatically prioritize urgent patients cases.
Shadow Mode
AI results appear on native images, where radiologists can review, accept, or reject, all within their workflow.
Part of Gleamer Copilot
Gleamer Copilot is the all-in-one AI platform that supports radiologists from image to report. It combines powerful detection tools, smart measurements, and structured reporting to boost accuracy and efficiency, all seamlessly integrated into your workflow.
Already implemented in
+2500
Clinical sites
We analyze
+45M
Patients/year
Worldwide presence in
+45
Countries
¹Radiologists without AI reached a sensitivity of 56% while standalone AI reached a sensitivity of 67% (Regnard et al., 2025 [Abstract ECR 2025])
² For lesions ≥ 20mm. Data based on ongoing MRMC study.
³Data based on ongoing MRMC study (general radiologists only).
For the latest regulatory information, refer to: https://www.gleamer.ai/privacy-policy